Lannett Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Lannett stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LCI, but not buy additional shares or sell existing shares.
View analyst ratings for Lannett or view top-rated stocks.

Wall Street analysts have given Lannett a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Lannett wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Lannett is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Lannett.

Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings results on Tuesday, August, 24th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.07. The business had revenue of $106 million for the quarter, compared to analyst estimates of $110.64 million. Lannett had a negative trailing twelve-month return on equity of 0.78% and a negative net margin of 75.92%. The firm's revenue was down 23.2% compared to the same quarter last year. During the same period last year, the firm earned $0.31 EPS.
View Lannett's earnings history.

Lannett's stock was trading at $7.74 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LCI stock has decreased by 60.3% and is now trading at $3.07.
View which stocks have been most impacted by COVID-19.

Lannett issued an update on its FY 2022 earnings guidance on Wednesday, September, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $400 million-$440 million, compared to the consensus revenue estimate of $472.06 million.

2 Wall Street analysts have issued 12 month price targets for Lannett's shares. Their forecasts range from $6.00 to $6.00. On average, they expect Lannett's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 95.4% from the stock's current price.
View analysts' price targets for Lannett or view top-rated stocks among Wall Street analysts.

9 employees have rated Lannett CEO Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among Lannett's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Lannett include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT) and Supernus Pharmaceuticals (SUPN).
View all of LCI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include (CELG), Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Lannett's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Telemus Capital LLC (18.72%), JPMorgan Chase & Co. (7.67%), Renaissance Technologies LLC (4.53%), LSV Asset Management (4.26%), Vanguard Group Inc. (3.73%) and Dimensional Fund Advisors LP (2.36%). Company insiders that own Lannett stock include David A Drabik, Jeffrey Farber, Patrick G Lepore and Timothy C Crew.
View institutional ownership trends for Lannett.

LCI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Vanguard Group Inc., Invesco Ltd., Bank of New York Mellon Corp, Northern Trust Corp, JPMorgan Chase & Co., and Geode Capital Management LLC.
View insider buying and selling activity for Lannett or view top insider-selling stocks.

LCI stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Ergoteles LLC, Oasis Management Co Ltd., Deutsche Bank AG, Susquehanna Fundamental Investments LLC, Tudor Investment Corp Et Al, Simplex Trading LLC, and Tibra Equities Europe Ltd. Company insiders that have bought Lannett stock in the last two years include Jeffrey Farber, Patrick G Lepore, and Timothy C Crew.
View insider buying and selling activity for Lannett or or view top insider-buying stocks.

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LCI stock can currently be purchased for approximately $3.07.

Lannett has a market capitalization of $129.79 million and generates $478.78 million in revenue each year. The company earns $-363,480,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis.

Lannett employs 954 workers across the globe.

The official website for Lannett is www.lannett.com.

Lannett is headquartered at 9000 STATE ROAD, PHILADELPHIA PA, 19136.

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at (215) 333-9000.